ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Mitochondrial dysfunction is a hallmark of β-amyloid (Aβ)–induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that Aβ-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Aβ to mitochondrial toxicity. Aβ interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of Aβ-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-Aβ interaction and suppresses Aβ-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an Aβ-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-Aβ interaction may be a therapeutic target in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, Aβ interacts specifically with mitochondrial Aβ-binding alcohol dehydrogenase (ABAD), impeding the binding of NAD to ABAD and inducing ROS production.287,288”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [287]
In the citing paper
“A number of studies have associated intraneuronal Ab buildup with hyperphosphorylation of tau protein, 8 disturbed protein trafficking and sorting, 9 reduced expression of synaptic proteins, 10 and mitochondrial dysfunction.11,12”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [11]
In the citing paper
“Aβ, and its precursor APP, localize, in part, to mitochondria in which they can cause mitochondrial dysfunction as evidenced by increased production of RS, enzyme inhibition, loss of cytochrome c, and depolarization of Δψm (Casley et al., 2002a; Kim et al., 2002; Anandatheerthavarada et al., 2003; Jang and Surh, 2003; Lustbader et al., 2004; Liang et al., 2009; Takuma et al., 2009).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
In the citing paper
“Aβ is reported to increase RS in neurons via multiple mechanisms, including direct Aβ-induced RS production, elevated NADPH oxidase activity, interaction with mitochondria-associated Aβ alcohol dehydrogenase, inhibition of cytochrome oxidase (respiratory complex IV), and by causing leakage of electrons from the mitochondrial electron transport chain (Hensley et al., 1994; Canevari et al., 1999; L”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
In the citing paper
“Intracellular Aβ may then enter the mitochondria in which it induces additional RS and magnifies the metabolic deficit”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M. W., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 999
Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472
TAT-Mediated Protein Transduction into Mammalian Cells
Becker-Hapak, M., McAllister, S. S., & Dowdy, S. F. (2001) · Methods · doi:10.1006/meth.2001.1186 · Cited by 384
Du Yan, S., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., et al. (1997) · Nature · doi:10.1038/39522 · Cited by 379
Self-citationRole of mitochondrial dysfunction in Alzheimer's disease
Castellani, R., Hirai, K., Aliev, G., Drew, K. L., Nunomura, A., Takeda, A., Cash, A. D., Obrenovich, M. E., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10389 · Cited by 364
Mitochondria in Alzheimer's disease
Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126
Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity
Du Yan, S., Shi, Y., Zhu, A., Fu, J., Zhu, H., Zhu, Y., Gibson, L., Stern, E., Collison, K., Al-Mohanna, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2145 · Cited by 120
Self-citationGrill, H. P., Zweier, J. L., Kuppusamy, P., Weisfeldt, M. L., & Flaherty, J. T. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90457-x · Cited by 108
Self-citation
Research works printed but not linked: 2
- M. A. Abreoet al. U.S. Patent and Trademark Office serial number 931186 (2002) vol. 9.
- We thank D. Eliezer and T. McGraw for helpful discussions K. D'Amico and L. Tong for help with data collection at the Advanced Photon Source and D. Landry for help with the surface plasmon resonance experiment. This work was supported by P50AG08702 AG16736 AG17490 and NS42855 and in part by Speaker's Fund for Biomedical Research and NIH 1K07AG00959. H.W. is a Pew Scholar of biomedical sciences and a Rita Allen Scholar. The atomic coordinates have been deposited in the Protein Data Bank (PDB accession code 1SO8).
Cited by
Items 601–700 of 1,002
Singh, P., Suman, S., Chandna, S., & Das, T. K. (2009) · Bioinformation · doi:10.6026/97320630003440 · Cited by 60
Pérez‐Cerdá, C., García‐Villoria, J., Ofman, R., Ruiz‐Sala, P., Merinero, B., Ramos, J., García‐Silva, M. T., Soto, B. B., Dalmau, J., Wanders, R. J. A., et al. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000176916.94328.cd · Cited by 56
Mitochondria in Aging and Alzheimer's Disease
Crouch, P. J., Cimdins, K., Duce, J. A., Bush, A. I., & Trounce, I. A. (2007) · Rejuvenation Research · doi:10.1089/rej.2007.0592 · Cited by 53
Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
Asik, R. M., Suganthy, N., Aarifa, M. A., Kumar, A., Szigeti, K., Máthé, D., Gulyás, B. Z., Archunan, G., & Padmanabhan, P. (2021) · Biomedicines · doi:10.3390/biomedicines9091126 · Cited by 56
Mitochondrial links between brain aging and Alzheimer’s disease
Wilkins, H., & Swerdlow, R. H. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00261-2 · Cited by 56
Mitochondria, cholesterol and amyloid β peptide: a dangerous trio in Alzheimer disease
Colell, A., Fernández, A., & Fernández-Checa, J. C. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9242-6 · Cited by 57
Systematic screens for human disease genes, from yeast to human and back
Perocchi, F., Mancera, E., & Steinmetz, L. M. (2007) · Molecular BioSystems · doi:10.1039/b709494a · Cited by 62
Zakaria, A., Hamdi, N., & Abdel-Kader, R. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9088-8 · Cited by 53
León, B. E., Kang, S., Franca-Solomon, G., Shang, P., & Choi, D. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.778456 · Cited by 64
Liu, J., Li, T., Zhong, G., Pan, Y., Gao, M., Su, S., Liang, Y., Ma, C., Liu, Y., Wang, Q., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115406 · Cited by 61
Alzheimer disease: modeling an Aβ-centered biological network
Campion, D., Pottier, C. P., Nicolas, G., Guennec, K. L., & Rovelet‐Lecrux, A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.38 · Cited by 61
Oka, S., Leon, J., Sakumi, K., Abolhassani, N., Sheng, Z., Tsuchimoto, D., LaFerla, F. M., & Nakabeppu, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-84640-9 · Cited by 51
miRNAs as Therapeutic Tools in Alzheimer’s Disease
Lee, C. Y., Ryu, I. S., Ryu, J., & Cho, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313012 · Cited by 62
Impaired Insulin Signaling and Mechanisms of Memory Loss
Bloemer, J., Bhattacharya, S., Amin, R., & Suppiramaniam, V. D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00013-2 · Cited by 57
Dumont, M., Stack, C., Elipenahli, C., Jainuddin, S., Launay, N., Gerges, M., Starkova, N., Starkov, A. A., Calingasan, N. Y., Tampellini, D., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-236331 · Cited by 50
Pascual‐García, A., Abia, D., Méndez, R., Nido, G. S., & Bastolla, U. (2010) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.22616 · Cited by 52
Environmental factors in the development and progression of late-onset Alzheimer’s disease
Wainaina, M. N., Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1425-9 · Cited by 58
Wang, H., Zhang, T., Ge, X., Chen, J., Zhao, Y., & Fu, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117322 · Cited by 55
Seo, J., Lee, K.-W., Kim, T., Baek, I., Im, J., & Han, P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.035 · Cited by 55
Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Yao, J., & Diaz Brinton, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072517 · Cited by 49
Yu, Q., Du, F., Douglas, J. T., Yu, H., Yan, S. S., & Yan, S. F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170283 · Cited by 53
Self-citationXu, J., Liu, J., Li, Q., Mi, Y., Zhou, D., Meng, Q., Chen, G., Li, N., & Hou, Y. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000711 · Cited by 53
Novel insights into RIPK1 as a promising target for future Alzheimer’s disease treatment
Li, S., Qu, L., Wang, X., & Kong, L. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107979 · Cited by 52
Onyango, I. G., Tuttle, J. B., & Bennett, J. P. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.02.012 · Cited by 56
Alberghina, L., & Colangelo, A. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-s1-s2 · Cited by 55
Yuan, C., & Gao, Z. (2013) · Chemical Research in Toxicology · doi:10.1021/tx300441e · Cited by 51
Belkacemi, A., & Ramassamy, C. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.020 · Cited by 53
Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer’s Disease?
Murphy, K. E., & Park, J. C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061168 · Cited by 53
Capriles, P. V. Z., Guimarães, A. C., Otto, T. D., de Miranda, A. B., Dardenne, L. E., & Degrave, W. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-610 · Cited by 55
Cao, L., Guan, P.-P., Zhang, S.-Q., Yang, Y., Huang, X., & Wang, P. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02327-4 · Cited by 51
Mechanisms of Mitochondrial Malfunction in Alzheimer’s Disease: New Therapeutic Hope
Nabi, S. U., Khan, A., Siddiqui, E. M., Rehman, M. U., Alshahrani, S., Arafah, A. M., Mehan, S., Alsaffar, R. M., Alexiou, A. T., & Shen, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4759963 · Cited by 55
Fang, D., Zhang, Z., Li, H., Yu, Q., Douglas, J. T., Bratasz, A., Kuppusamy, P., & Yan, S. S. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150917 · Cited by 48
Self-citationMitochondrial Perturbation in Alzheimer's Disease and Diabetes
Akhter, F., Chen, D., Yan, S. F., & Yan, S. S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.019 · Cited by 50
Self-citationZong, W., Zeng, X., Chen, S., Chen, L., Zhou, L., Wang, X., Gao, Q., Zeng, G., Hu, K., & Ouyang, D. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.01.013 · Cited by 49
The role of mitochondrial defects and oxidative stress in Alzheimer’s disease
Islam, B. U., Jabir, N. R., & Tabrez, S. S. M. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1584808 · Cited by 48
de Dios, C., Bartolessis, I., Roca-Agujetas, V., Barbero-Camps, E., Mari, M., Morales, A., & Colell, A. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101283 · Cited by 47
Pinto, M., Pickrell, A. M., Fukui, H., & Moraes, C. T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.014 · Cited by 47
Froemming, M. K., & Sameš, D. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072601x · Cited by 47
Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal
Sandhir, R., & Gupta, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1223 · Cited by 49
Targeting TRPM2 in ROS-Coupled Diseases
Yamamoto, S., & Shimizu, S. (2016) · Pharmaceuticals · doi:10.3390/ph9030057 · Cited by 51
Kam, T.-I., Park, H., Gwon, Y., Song, S., Kim, S.-H., Moon, S. W., Jo, D.-G., & Jung, Y.-K. (2016) · eLife · doi:10.7554/elife.18691 · Cited by 49
Dong, Y.-T., Cao, K., Tan, L.-C., Wang, X.-L., Qi, X.-L., Xiao, Y., & Guan, Z.-Z. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-171020 · Cited by 48
Sarkar, S., Jun, S., & Simpkins, J. W. (2015) · Brain Research · doi:10.1016/j.brainres.2015.04.059 · Cited by 47
Tillement, L., Lecanu, L., Yao, W., Greeson, J., & Papadopoulos, V. (2006) · Steroids · doi:10.1016/j.steroids.2006.05.003 · Cited by 52
Coon, K. D., Valla, J., Szelinger, S., Schneider, L. E., Niedzielko, T. L., Brown, K. M., Pearson, J. V., Halperin, R. F., Dunckley, T. L., Papassotiropoulos, A., et al. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.07.002 · Cited by 51
Kshirsagar, S., Alvir, R. V., Pradeepkiran, J. A., Hindle, A., Vijayan, M., Ramasubramaniam, B., Kumar, S., Reddy, A. P., & Reddy, P. H. (2022) · Cells · doi:10.3390/cells11172660 · Cited by 49
RetractedGhobeh, M., Ahmadian, S., Meratan, A. A., Ebrahim‐Habibi, A., Ghasemi, A., Shafizadeh, M., & Nemat‐Gorgani, M. (2014) · Biopolymers · doi:10.1002/bip.22572 · Cited by 51
The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation
Pickrell, A. M., Fukui, H., & Moraes, C. T. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9245-3 · Cited by 47
Jin, H., Liu, T., Wang, W., Xu, J., Yang, P., Lü, H., Sun, Q., & Hu, H. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.11.015 · Cited by 49
Bignante, E. A., Heredia, F., Morfini, G. A., & Lorenzo, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.021 · Cited by 60
Lei, H., Zhao, C., Liu, D.-M., Zhang, Y., Li, L., Wang, X., & Peng, Y. (2014) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2014.939586 · Cited by 48
HIG1, a novel regulator of mitochondrial γ‐secretase, maintains normal mitochondrial function
Hayashi, H., Nakagami, H., Takeichi, M., Shimamura, M., Koibuchi, N., Oiki, E., Sato, N., Koriyama, H., Mori, M., Araujo, R. G., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-196063 · Cited by 56
Development of new fusion proteins for visualizing amyloid-β oligomers in vivo
Ochiishi, T., Doi, M., Yamasaki, K., Hirose, K., Kitamura, A., Urabe, T., Hattori, N., Kinjo, M., Ebihara, T., & Shimura, H. (2016) · Scientific Reports · doi:10.1038/srep22712 · Cited by 46
Redmann, M., Benavides, G. A., Wani, W. Y., Berryhill, T. F., Ouyang, X., Johnson, M. S., Ravi, S., Mitra, K., Barnes, S., Darley-Usmar, V. M., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.04.005 · Cited by 50
De, R., Mazumder, S., & Bandyopadhyay, U. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09561-1 · Cited by 51
Calió, M. L., Mosini, A. C., Marinho, D. S., Salles, G. N., Massinhani, F. H., Ko, G. M., & Porcionatto, M. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105219 · Cited by 47
The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions
Kaneko, K., & Hachiya, N. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.019 · Cited by 46
Strategic Role for Mitochondria in Alzheimer's Disease and Cancer
Hedskog, L., Zhang, S., & Ankarcrona, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4259 · Cited by 47
Valasani, K. R., Sun, Q., Fang, D., Zhang, Z., Yu, Q., Guo, Y., Li, J., Roy, A., & ShiDu Yan, S. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00451 · Cited by 44
Self-citationAssociation between Sleep, Alzheimer’s, and Parkinson’s Disease
Matsumoto, S., & Tsunematsu, T. (2021) · Biology · doi:10.3390/biology10111127 · Cited by 47
Chung, J. Y., Kim, O. Y., & Song, J. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab118 · Cited by 50
Serviddio, G., Davide Romano, A., Cassano, T., Bellanti, F., Altomare, E., & Vendemiale, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796904740 · Cited by 46
Hydroxysteroid (17β) dehydrogenase X in human health and disease
Yang, S., He, X., & Miller, D. L. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.011 · Cited by 47
Amyloid precursor protein‐mediated mitochondrial regulation and Alzheimer's disease
Lopez Sanchez, M. I. G., van Wijngaarden, P., & Trounce, I. A. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14554 · Cited by 45
Mishra, A., Wang, Y., Yin, F., Vitali, F., Rodgers, K. E., Soto, M., Mosconi, L., Wang, T., & Brinton, R. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101542 · Cited by 60
Li, R., Wang, L., Duan, H., Zhang, Q., Guo, X., Wu, C., & Peng, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.937289 · Cited by 60
Spina, E., Ferrari, R. R., Pellegrini, E., Colombo, M. M., Poloni, T. E., Guaita, A., & Davin, A. (2025) · Cells · doi:10.3390/cells14030229 · Cited by 48
Mitophagy in Neurons: Mechanisms Regulating Mitochondrial Turnover and Neuronal Homeostasis
Basak, B., & Holzbaur, E. L. F. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169161 · Cited by 46
Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
Moreira, P. I., Cardoso, S. M., Pereira, C., Santos, M. S., & Oliveira, C. R. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824651 · Cited by 48
Amyloidosis in Retinal Neurodegenerative Diseases
Masuzzo, A., Dinet, V., Cavanagh, C., Mascarelli, F., & Krantic, S. M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00127 · Cited by 51
Lone, A., Harris, R. A., Singh, O., Betts, D. H., & Cumming, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-35114-y · Cited by 47
Shen, Y., Ding, M., Xie, Z., Liu, X., Yang, H., Jin, S., Xu, S., Zhu, Z., Wang, Y., Wang, D., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00568 · Cited by 47
Atlante, A., Valenti, D., Latina, V., & Amadoro, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147722 · Cited by 45
Bertolin, G., Jacoupy, M., Traver, S., Ferrando-Miguel, R., Saint-Georges, T., Grenier, K., Ardila-Osorio, H., Mp, M., Takahashi, H., Lees, A. J., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.224 · Cited by 48
Genetic basis of Alzheimer's dementia: role of mtDNA mutations
Grazina, M., Pratas, J., Silva, F., Oliveira, S., Santana, I., & Oliveira, C. (2006) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00225.x · Cited by 45
Mitochondrial medicine and the neurodegenerative mitochondriopathies
Swerdlow, R. H. (2009) · Pharmaceuticals · doi:10.3390/ph2030150 · Cited by 43
Mahley, R. W. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102684 · Cited by 43
Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies
Meng, X., Zhang, H., Zhao, Z., Li, S., Zhang, X., Guo, R., Li, H., Yuan, Y., Li, W., Song, Q., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01101-z · Cited by 50
The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases
Carvalho, C., Correia, S. C., Cardoso, S., Plácido, A. I., Candeias, E., Duarte, A. I., & Moreira, P. I. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1058160 · Cited by 52
Head, E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.004 · Cited by 50
Dong, Y., Stewart, T., Zhang, Y., Shi, M. Y., Tan, C., Li, X., Yuan, L., Mehrotra, A., Zhang, J., & Yang, X. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9350-1 · Cited by 44
17B-hydroxysteroid dehydrogenases as acyl thioester metabolizing enzymes
Hiltunen, J. K., Kastaniotis, A. J., Autio, K. J., Jiang, G., Chen, Z., & Glumoff, T. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.11.012 · Cited by 43
Wang, Y., Wu, L., Li, J., Fang, D., Zhong, C., Chen, J. X., & Yan, S. S. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140972 · Cited by 42
Self-citationA New Function of Human HtrA2 as an Amyloid-β Oligomerization Inhibitor
Kooistra, J., Milojevic, J., Melacini, G., & Ortega, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1037 · Cited by 50
Zhao, L., Gong, N., Liu, M., Pan, X., Sang, S., Sun, X., Yu, Z., Fang, Q., Zhao, N., Fei, G., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.003 · Cited by 44
Nitric Oxide Links Mitochondrial Fission to Alzheimer’s Disease
Westermann, B. (2009) · Science Signaling · doi:10.1126/scisignal.269pe29 · Cited by 47
Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers
Wang, H., Muiznieks, L. D., Ghosh, P., Williams, D., Solarski, M., Fang, A., Ruiz‐Riquelme, A., Pomès, R., Watts, J. C., Chakrabartty, A., et al. (2017) · eLife · doi:10.7554/elife.28401 · Cited by 52
Herrmann, A. G., Deighton, R. F., Bihan, T. L., McCulloch, M. C., Searcy, J. L., Kerr, L. E., & McCulloch, J. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.204 · Cited by 43
McIntee, F. L., Giannoni, P., Blais, S., Sommer, G., Neubert, T. A., Rostagno, A., & Ghiso, J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00223 · Cited by 42
Ginsenoside Rb1 inhibit apoptosis in rat model of Alzheimer's disease induced by Aβ1-40.
Wang, Y., Li, Y., Yang, W., Gao, S., Lin, J., Wang, T., Zhou, K., & Hu, H. (2018) · PubMed · Cited by 42
Villa, C., Suphesiz, H., Combi, R., & Akyüz, E. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111197 · Cited by 42
Hongo, N., Takamura, Y., Nishimaru, H., Matsumoto, J., Kazuyuki, T., Saito, T., Saido, T. C., & Nishijo, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00307 · Cited by 43
Friend or enemy? Review of 17β‐HSD10 and its role in human health or disease
Vinklářová, L., Schmidt, M., Benek, O., Kuča, K., Gunn, F. J., & Musílek, K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15027 · Cited by 46
Self-citationMast, J. D., Tomalty, K. M. H., Vogel, H. S., & Clandinin, T. R. (2008) · Development · doi:10.1242/dev.020644 · Cited by 45
14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein
Omi, K., Hachiya, N., Tanaka, M., Tokunaga, K., & Kaneko, K. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.018 · Cited by 48
Ginsenoside Rg1 Attenuates Oligomeric Aβ1-42-Induced Mitochondrial Dysfunction
Huang, T., Fang, F., Chen, L., Zhu, Y., Zhang, J., Chen, X., & Yan, S. S. (2012) · Current Alzheimer Research · doi:10.2174/156720512800107636 · Cited by 43
Self-citationOligo(ethylene glycol) Derivatives of Thioflavin T as Inhibitors of Protein–Amyloid Interactions
Inbar, P., Li, C. Q., Takayama, S. A., Bautista, M. R., & Yang, J. (2006) · ChemBioChem · doi:10.1002/cbic.200600119 · Cited by 53
Novel Benzothiazole-Based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer’s Disease Treatment
Aitken, L., Benek, O., McKelvie, B. E., Hughes, R. E., Hroch, L., Schmidt, M., Major, L. L., Vinklářová, L., Kuča, K., Smith, T., et al. (2019) · Molecules · doi:10.3390/molecules24152757 · Cited by 42
Self-citationLi, Q., Mok, S. S., Laughton, K. M., McLean, C., Volitakis, I., Cherny, R. A., Cheung, N. S., White, A. R., & Masters, C. L. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00200.x · Cited by 45
Xi, Y., Yu, H., Ma, W., Ding, B., Ding, J., Yuan, L., Feng, J., & Xiao, R. (2011) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-011-9362-7 · Cited by 44
Metadata
- Authors
- Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., Trinchese, F., Liu, S., Gunn-Moore, F., Lue, L.-F., Walker, D. G., Kuppusamy, P., Zewier, Z. L., Arancio, O., Stern, D., Yan, S. S., & Wu, H.
- Affiliations
- Harbin Medical University (CN)
- Center for Reproductive Sciences and Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.
- Corresponding author
- Lustbader, Joyce W.
- Cirilli, Maurizio
- Lin, Chang
- Takuma, Kazuhiro
- Wang, Ning
- Yan, Shirley ShiDu
- Wu, Hao
- ORCID
- Venue
- Science
- Published
- 2004-04-16
- Volume
- 304
- Issue
- 5669
- Pages
- 448-452
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2163757074
- Cited by
- 1,303
- References
- 22
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 43 · 2023: 51 · 2022: 53 · 2021: 64 · 2020: 73 · 2019: 63 · 2018: 61 · 2017: 55 · 2016: 71 · 2015: 42 · 2014: 62 · 2013: 59 · 2012: 76
- FWCI
- 38.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-17490, AG 16736, K07AG000959, P50AG008702, P01AG017490, R01AG016736)
- National Institute of Neurological Disorders and Stroke (NS 42855, R01NS042855)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, alcohol dehydrogenase, mitochondrial toxicity, mitochondrial dysfunction, NAD+ binding, protein-protein interaction, oxidative stress, neuronal apoptosis, free radicals, memory impairment, therapeutic target
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amino Acid Sequence, Animals, Binding Sites, Brain, Brain Chemistry, Carrier Proteins, Cells, Cultured, Cerebral Cortex, Crystallization, Hippocampus, Humans, Learning, Memory, Mice, Transgenic, Mitochondria, Models, Molecular, Molecular Sequence Data, Mutation, NAD, Neurons, Protein Binding, Protein Conformation, 3-Hydroxyacyl CoA Dehydrogenases, Amyloid beta-Peptides, Microscopy, Immunoelectron, Reactive Oxygen Species, Microscopy, Confocal, Mice, DNA Fragmentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.